[Ip-health] "Engineered in India: Patent Law 2.0"
amy.kapczynski at yale.edu
Mon Jul 29 12:14:52 PDT 2013
Perhaps of interest: I've just published this short article about the Novartis case in the New England Journal of Medicine. It makes a set of arguments that will be familiar to people here – i.e. that the Novartis case struck an important blow for access, and that Section 3(d) should be a model for other countries — not only because it promotes access, but because — if adopted widely -- it might encourage companies to focus on breakthrough innovation rather than incremental innovation.
"Engineered in India: Patent Law 2.0"
(also available here: http://www.nejm.org/online-first)
More information about the Ip-health